Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Apr 16;10(11):3573-3578.
doi: 10.12998/wjcc.v10.i11.3573.

Qingchang decoction retention enema may induce clinical and mucosal remission in left-sided ulcerative colitis: A case report

Affiliations
Case Reports

Qingchang decoction retention enema may induce clinical and mucosal remission in left-sided ulcerative colitis: A case report

Pei-Han Li et al. World J Clin Cases. .

Abstract

Background: Ulcerative colitis (UC) is a chronic autoimmune disease characterized by relapsing-remitting abdominal pain, diarrhea, mucopurulent discharge and rectal bleeding. To date, the etiology of the disease remains unknown; therefore, medical therapy is not yet available. Left-sided UC is mainly treated with oral and topical mesalazine. However, due to its modest clinical effect, endoscopic mucosal remission is not achieved in all patients.

Case summary: A 44-year-old man presented to Longhua Hospital with a history of left-sided UC for more than 6 years and slight bloody diarrhea over time. Endoscopy suggested hyperemia, edema, and erosive mucosa involving the rectum and sigmoid colon. The Traditional Chinese medicine Qingchang decoction (QCD) enema treatment was initiated once a day combined with a previous standard dose of mesalazine for 8 wk, and rectal bleeding ceased after 4 wk of treatment. Another QCD enema treatment was provided after symptom relapse due to drug withdrawal for nearly 6 mo. At the 2-mo follow-up, the colonoscopy results indicated mucosal healing with no erosion or ulcers.

Conclusion: The Chinese formula QCD retention enema represents a potential treatment for left-sided UC with predominant rectal bleeding to achieve clinical and mucosal remission.

Keywords: Case report; Chinese formulas; Qingchang decoction enema; Qingchang suppository; Ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Endoscopic images before Qingchang decoction retention enema treatment. A: Colonoscopy image showing hyperemia, edema, erosions, and friability in the sigmoid colon; B: Colonoscopy image showing hyperemia, edema, erosions, and friability in the rectum.
Figure 2
Figure 2
Endoscopic images after Qingchang decoction retention enema treatment. A: Colonoscopy image showing normal mucosa in the sigmoid colon; B: Colonoscopy image showing patchy hyperemia in the rectum.

References

    1. Inflammatory Bowel Disease Group; Chinese Society of Gastroenterology (CSG), Chinese Medical Association. A consensus view on the diagnosis and treatment of inflammatory bowel disease (IBD) Zhonghua Xiaohua Zazhi. 2018;38:292–311.
    1. Chinese inflammatory bowel disease cooperative group. Retrospective analysis of 3100 hospitalized cases of ulcerative colitis. Zhonghua Xiaohua Zazhi. 2006;26:368–372.
    1. Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F European Crohn’s and Colitis Organisation [ECCO] Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. J Crohns Colitis. 2017;11:769–784. - PubMed
    1. Yashiro M. Ulcerative colitis-associated colorectal cancer. World J Gastroenterol. 2014;20:16389–16397. - PMC - PubMed
    1. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114:384–413. - PubMed

Publication types